Dynamics of PD-1 expression are associated with treatment efficacy and prognosis in patients with intermediate/high-risk myelodysplastic syndromes under hypomethylating treatment.

Front Immunol · 2022 · PMC9393298 · PMID 36003379

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Similar trends of up/down-regulated PD-L1 and PD-L2 were also seen in these MDS patients, while these differences did not reach statistical significance during HMA treatment cycles ( Figures 3B, C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.